Physician profile
Oliver Ali
NPI 1932334612
$1,960.00
in general payments reported to CMS, 2019-2025
13 companies · $523 in 2025
The $523 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.16 · 2020: $130 · 2021: $138 · 2022: $38.48 · 2023: $457 · 2024: $580 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,462 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,462.32 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $579.62 | 2022-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $374.94 | 2023-2025 | Precision 1, Total30, Dailies Total1 |
| Mallinckrodt Hospital Products INC. | $212.09 | 2023 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $150.09 | 2019-2021 | |
| Harrow Eye, LLC | $122.20 | 2024 | Vevye |
| Sun Pharmaceutical Industries INC. | $101.81 | 2023 | Cequa |
| Ocular Therapeutix, INC. | $88.46 | 2024 | |
| Horizon Therapeutics Plc | $88.02 | 2021 | |
| Biotissue Holdings INC. | $72.39 | 2020-2024 | |
| Coopervision INC. | $67.66 | 2022-2025 | Misight Contact Lens |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $38.63 | 2023-2024 | Acuvue |
| Allergan, INC. | $25.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.